VERV’s latest rating updates from top analysts.
Verve Therapeutics Inc’s filing revealed that its Chief Administrative Officer Nickerson Joan unloaded Company’s shares for reported $12475.0 on Apr
Verve Therapeutics Inc’s filing revealed that its Chief Administrative Officer Nickerson Joan unloaded Company’s shares for reported $12475.0 on Apr
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Verve Therapeutics
Verve Therapeutics Inc’s recent filing unveils that its Chief Administrative Officer Nickerson Joan unloaded Company’s shares for reported $12475.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Verve Therapeutics Inc revealed its Chief Administrative Officer Nickerson Joan unloaded Company’s shares for reported $12475.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Verve Therapeutics
Verve Therapeutics Inc’s recently made public that its Chief Administrative Officer Nickerson Joan unloaded Company’s shares for reported $12475.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Verve Therapeutics Inc revealed its Chief Administrative Officer Nickerson Joan unloaded Company’s shares for reported $12475.0 on
Verve Therapeutics Inc. (NASDAQ:VERV) does about 768.12K shares in volume on a normal day but saw 618802 shares change hands